Squamous Cell Carcinoma Antigen
Squamous Cell Carcinoma Antigen (SCC) is a tumour marker associated with squamous cell carcinomas, including cancers of the cervix, lung, head and neck, oesophagus, and anus. The SCC antigen is a glycoprotein released by malignant squamous cells and may be detected in the bloodstream. While SCC testing is not typically used as a primary screening tool, it may assist in monitoring disease progression, treatment response, or recurrence in patients with known squamous cell carcinoma.
- Price: £128
- Code: SCC
- TAT: 10 Working Days
- Sample Type: Blood
Clinical Significance
Elevated SCC levels may correlate with tumour burden in certain squamous cell carcinomas. Serial measurement can help assess response to chemotherapy, radiotherapy, or surgical treatment. Rising levels following treatment may indicate possible recurrence and prompt further investigation. However, SCC antigen is not entirely specific for malignancy. Mild elevations may occur in benign conditions such as psoriasis, eczema, chronic lung disease, or inflammatory states. Therefore, results must always be interpreted in conjunction with clinical findings and imaging. SCC testing is most useful when used for monitoring known cancer rather than for initial diagnosis.
Who Might Benefit From This Test?
This test may be appropriate for individuals with diagnosed squamous cell carcinoma undergoing treatment or follow-up. It may also be requested when recurrence is suspected based on symptoms or imaging findings. Clinicians may incorporate SCC antigen measurement into structured oncology monitoring protocols.
Sample Collection
A blood sample is obtained by a qualified healthcare professional. The procedure is straightforward and completed within minutes. Samples are analysed in accredited laboratories to ensure reliable tumour marker measurement.
Understanding Your Results
Elevated levels may reflect tumour activity, though interpretation depends on cancer type, stage, and clinical context. Stable or declining levels during treatment may suggest therapeutic response. Because non-malignant conditions can occasionally elevate SCC, results are not interpreted in isolation. Further imaging or specialist referral may be recommended where clinically indicated.
FAQs
When will I receive my results?
Results are usually available within the stated turnaround time.
Should I discuss my results with a doctor?
Yes, results should always be reviewed with a qualified healthcare professional.
Why Choose Marylebone Diagnostic Centre?
Marylebone Diagnostic Centre provides comprehensive oncology-related laboratory testing within a professional and discreet environment. With a turnaround time of 10 days, this test supports careful monitoring and timely clinical decision-making.
Book Now
Book the Squamous Cell Carcinoma Antigen (SCC) test today to support structured cancer monitoring and follow-up care.
